News - Three members of Anges Québec, including angel investor Maxime Detraux, have invested $400 K in Gullivert Technologies, which can also count on a $200 K investment from Desjardins Innovatech. The Quebec company has redesigned the mechanics of industrial air compressors and developed the only technology in the world capable of compressing gas directly using belt technology, allowing industries to reduce their energy consumption.
News - Scenic bike rides will never be the same now that there's CycleMap, a mobile application created by David Boudreault and Olivier Carbonneau, two young techno entrepreneurs, and cyclists in their free time. In no time at all, CycleMap allows bikers to find the best route possible anywhere in the world for a ride alone or with family!
News - CRIQ has signed an agreement with the Mexican state of Jalisco's Ministry of Innovation, Science, and Technology and the Mexican Institute of Water Technology (IMTA) to implement biofiltration wastewater treatment technology in two locations: a pig farm and a producer of Mexico's world famous Tequila.
News - Atrium Innovations, a globally recognized leader in the development, manufacturing, and commercialization of innovative, science-based, natural health products, is proud to announce its diamond sponsorship of BÉNÉFIQ 2014, an international rendezvous in Quebec City, Canada dedicated to health ingredients.
News - Teralys Capital, along with co-investors Fonds de solidarité FTQ and the Business Development Bank of Canada (BDC), announced today that they are proud to invest in and be working with Versant Ventures on the expansion of the successful Inception Sciences incubator to Montréal. Teralys maintains its leadership role in structuring Quebec's life sciences ecosystem while strengthening its international position in this critical sector.
News - EXFO announced today it has received an order worth approximately US$2 million from a global tier-1 mobile network operator for the complete assessment of its mobile backhaul network infrastructure, from turn-up to real-time monitoring and advanced troubleshooting. EXFO's Ethernet One solution, including BrixNGN service assurance software, BV-3100 Verifiers, and FTB-1 field-portable platforms, was awarded the order based on its ability to meet enhanced service performance delivery, increased operational efficiency, and accelerated time-to-revenue requirements of the global mobile network operator.
News - Are you looking to access more working capital or finance your international business expansion? EDC has a range of flexible financing solutions, to help meet the financing needs of your company, your foreign subsidiary or your foreign customer.
News - EXFO announced today it has acquired the business of Aito Technologies, a leading provider of customer experience analytics for mobile network operators (MNOs), through an asset purchase deal. Based in Espoo, Finland, Aito Technologies offers out-of-the-box customer experience analytics software that unifies business, network, product and customer data for real-time analysis, discovery, reaction and decision support for a wide range of users and decision-makers within a wireless operator organization.
News - Manac, a North American leader in the design and manufacturing of specialty trailers, announces today the acquisition of all of the issued and outstanding shares of Peerless Limited for $14.75 million in cash, subject to certain net working capital adjustments. Established in Penticton, British Columbia, Peerless is a designer and manufacturer of highly specialized trailers and chassis for a variety of industries, including oil and gas, mining, forestry, logging and construction. Peerless had been operating the Mobile Solution division of McCoy Corporation since 2004.
News - Asmacure Ltee, a clinical-stage biopharmaceutical company focused on the development of novel, proprietary compounds that target cholinergic receptors for the treatment of pulmonary diseases, today announced top-line results from a combined Phase 1 and 2a trial evaluating its lead compound, ASM-024, in moderate asthma patients.